7月15日，港股医疗器械龙头威高股份（01066）于二级市场实施股份回购计划，以每股5.85港元均价购入8万股公司股份。此次回购总耗资达46.76万港元，彰显管理层对企业长期价值的信心。
此次操作延续了公司今年以来的回购策略。值得注意的是，本次交易价格较前一交易日收盘价存在0.85%的折让，反映公司精准把握了市场波动中的窗口机遇。作为国内医用耗材领域的领军企业，威高股份通过自有资金持续回购流通股，有效优化了资本结构，向市场传递出积极的估值修复信号。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.